Bio-Techne Corporation
TECH · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $1,219,635 | $1,159,060 | $1,136,702 | $1,105,599 |
| % Growth | 5.2% | 2% | 2.8% | – |
| Cost of Goods Sold | $429,363 | $389,335 | $366,887 | $349,103 |
| Gross Profit | $790,272 | $769,725 | $769,815 | $756,496 |
| % Margin | 64.8% | 66.4% | 67.7% | 68.4% |
| R&D Expenses | $99,496 | $96,664 | $92,493 | $87,140 |
| G&A Expenses | $415,097 | $393,320 | $352,438 | $339,001 |
| SG&A Expenses | $415,097 | $393,320 | $352,438 | $339,001 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $173,424 | $73,055 | $25,940 | $33,765 |
| Operating Expenses | $688,017 | $563,039 | $470,871 | $459,906 |
| Operating Income | $102,255 | $206,686 | $298,944 | $296,590 |
| % Margin | 8.4% | 17.8% | 26.3% | 26.8% |
| Other Income/Exp. Net | -$3,792 | -$20,997 | $39,715 | $4,796 |
| Pre-Tax Income | $98,463 | $185,689 | $338,659 | $301,386 |
| Tax Expense | $25,063 | $17,584 | $53,217 | $38,287 |
| Net Income | $73,400 | $168,105 | $285,263 | $272,051 |
| % Margin | 6% | 14.5% | 25.1% | 24.6% |
| EPS | 0.47 | 1.07 | 1.81 | 1.73 |
| % Growth | -56.1% | -40.9% | 4.6% | – |
| EPS Diluted | 0.46 | 1.05 | 1.76 | 1.66 |
| Weighted Avg Shares Out | 157,521 | 157,708 | 157,179 | 156,876 |
| Weighted Avg Shares Out Dil | 159,717 | 160,774 | 161,855 | 164,116 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,886 | $3,323 | $3,410 | $794 |
| Interest Expense | $8,509 | $15,736 | $11,215 | $11,309 |
| Depreciation & Amortization | $109,903 | $111,711 | $107,238 | $101,069 |
| EBITDA | $216,875 | $313,136 | $457,112 | $413,764 |
| % Margin | 17.8% | 27% | 40.2% | 37.4% |